In addition, derivative 1d was found to be a novel potent selective inhibitor of protein tyrosine phosphatase 1B (PTP1B, IC50 = 8.96 μM), a potential target for treating type II diabetes and obesity [11]. Here, PTPN1 is linked to obesity due to melanocortin 4 receptor deficiency.